# CareSync

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/caresync

- Industry: Healthcare IT
- Headquarters: Tampa, US
- Website: www.caresync.com
- Total disclosed funding: $49M
- Latest round: Series B (Aug 1, 2017)
- Investors on record: 9

## About

CareSync, Inc. is a healthcare technology company focused on improving care coordination and patient engagement through innovative solutions. Their services enhance the interaction between patients and healthcare providers, leading to better health outcomes.Founded in 2011 and headquartered in Tampa, US, CareSync, Inc. specializes in healthcare technology solutions that streamline care coordination. The company was acquired by Vatica Health, Inc. in January 2019, although specific financial terms were not disclosed. Lisa Ashby is the current CEO, while Sim Deol is noted as the founder. Since its inception, CareSync has participated in five funding deals, with its most recent funding round being a Series B in which they raised USD 26.50 mn, led by Merck Global Health Innovation Fund alongside other investors like Greycroft Partners and Headline.CareSync, Inc. offers a range of healthcare technology services aimed at improving patient engagement and care coordination. This includes solutions that facilitate better communication between patients and providers, assisting with chronic care management and appointment scheduling, thereby enhancing overall patient satisfaction and health outcomes.CareSync, Inc. operates primarily on a subscription-based revenue model, generating income through partnerships with healthcare providers and payers. Their services are designed to fit seamlessly into existing healthcare workflows, helping improve operational efficiency without disclosing specific revenue figures.Looking forward, CareSync, Inc. aims to expand its offerings with new technology solutions tailored for healthcare providers, although specific product launches or timelines have not been disclosed. The company is targeting growth in new markets, especially focusing on enhancing its presence in both urban and rural healthcare settings. The recent funding of USD 26.50 mn will support these initiatives by providing necessary resources for development and market expansion.

## Funding rounds

- Series B, Aug 1, 2017, $27M — Headline, Greycroft, Ropart Asset Management Funds, Merck Global Health Innovation Fund, Sovereign's Capital
- Series B, Dec 2, 2016 — Sovereign's Capital
- Series B, Oct 7, 2015, $18M — Tullis Health Investors, CDH Investments, Harbert Management, Greycroft, Merck Global Health Innovation Fund, Clearwell Advisors
- Series A, Oct 21, 2014, $4.3M — Tullis Health Investors, CDH Investments, Clearwell Advisors

## Investors

- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series A, Series B
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series A, Series B
- Clearwell Advisors — Series A, Series B
- Harbert Management (https://capitalatlas.ai/funds/harbert-management) — Series B
- Greycroft (https://capitalatlas.ai/funds/greycroft) — Series B
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series B
- Sovereign's Capital (https://capitalatlas.ai/funds/sovereign-s-capital) — Series B
- Headline (https://capitalatlas.ai/funds/headline) — Series B
- Ropart Asset Management Funds (https://capitalatlas.ai/funds/ropart-asset-management-funds) — Series B